Met Life Investment Management, LLC Harmony Biosciences Holdings, Inc. Transaction History

Met Life Investment Management, LLC

$17.1 Billion
Q3 2024

A detailed history of Met Life Investment Management, LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 17,885 shares of HRMY stock, worth $609,163. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,885

Previous 19,282 7.25%

Holding current value

$609,163

Previous $581,000 22.89%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$30.0 - $39.95 $41,910 - $55,810	-1,397 Reduced 7.25%	17,885 $714,000
Q2 2024 Aug 13, 2024	BUY	$28.81 - $33.01 $49,985 - $57,272	1,735 Added 9.89%	19,282 $581,000
Q1 2024 May 14, 2024	BUY	$29.93 - $35.06 $525,181 - $615,197	17,547 New	17,547 $589,000
Q3 2023 May 09, 2024	BUY	$31.89 - $39.03 $104,439 - $127,823	3,275 Added 22.95%	17,547 $575,000
Q2 2023 Apr 29, 2024	BUY	$30.5 - $37.4 $535,183 - $656,257	17,547 New	17,547 $617,000
Q2 2023 Aug 10, 2023	BUY	$30.5 - $37.4 $99,887 - $122,485	3,275 Added 22.95%	17,547 $617,000
Q1 2023 May 09, 2024	BUY	$30.8 - $53.92 $439,577 - $769,546	14,272 New	14,272 $466 Million
Q2 2022 May 10, 2024	BUY	$33.54 - $52.15 $19,285 - $29,986	575 Added 4.2%	14,272 $696,000
Q2 2022 Mar 22, 2023	BUY	$33.54 - $52.15 $19,285 - $29,986	575 Added 4.2%	14,272 $696,000
Q2 2022 Aug 11, 2022	BUY	$33.54 - $52.15 $19,285 - $29,986	575 Added 4.2%	14,272 $696,000
Q1 2022 May 10, 2024	BUY	$33.14 - $51.13 $453,918 - $700,327	13,697 New	13,697 $666,000
Q1 2022 Jun 20, 2023	SELL	$33.14 - $51.13 $19,055 - $29,399	-575 Reduced 4.03%	13,697 $666,000
Q1 2022 Mar 22, 2023	BUY	$33.14 - $51.13 $144,490 - $222,926	4,360 Added 46.7%	13,697 $666,000
Q1 2022 May 12, 2022	BUY	$33.14 - $51.13 $144,490 - $222,926	4,360 Added 46.7%	13,697 $666,000
Q4 2021 Jun 21, 2023	SELL	$34.09 - $43.91 $168,234 - $216,695	-4,935 Reduced 34.58%	9,337 $398,000
Q3 2021 Jun 21, 2023	SELL	$25.68 - $38.61 $126,730 - $190,540	-4,935 Reduced 34.58%	9,337 $357,000
Q2 2021 May 17, 2024	SELL	$25.96 - $33.44 $213,131 - $274,542	-8,210 Reduced 46.79%	9,337 $263,000
Q2 2021 Jun 21, 2023	SELL	$25.96 - $33.44 $128,112 - $165,026	-4,935 Reduced 34.58%	9,337 $263,000
Q2 2021 Mar 22, 2023	SELL	$25.96 - $33.44 $128,112 - $165,026	-4,935 Reduced 34.58%	9,337 $263,000
Q2 2021 Aug 16, 2021	BUY	$25.96 - $33.44 $242,388 - $312,229	9,337 New	9,337 $264,000

Others Institutions Holding HRMY

# of Institutions

242

Shares Held

45.1M

Call Options Held

108K

Put Options Held

49.2K

View Full List

About Harmony Biosciences Holdings, Inc.

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.02B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

More about HRMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account

Met Life Investment Management, LLC Harmony Biosciences Holdings, Inc. Transaction History